» Articles » PMID: 29028977

Evolving Understanding of the Causes of Pneumonia in Adults, With Special Attention to the Role of Pneumococcus

Overview
Journal Clin Infect Dis
Date 2017 Oct 14
PMID 29028977
Citations 76
Authors
Affiliations
Soon will be listed here.
Abstract

Before 1945, Streptococcus pneumoniae caused more than 90% of cases of pneumonia in adults. After 1950, the proportion of pneumonia caused by pneumococcus began to decline. Pneumococcus has continued to decline; at present, this organism is identified in fewer than fewer10%-15% of cases. This proportion is higher in Europe, a finding likely related to differences in vaccination practices and smoking. Gram-negative bacilli, Staphylococcus aureus, Chlamydia, Mycoplasma, and Legionella are each identified in 2%-5% of patients with pneumonia who require hospitalization. Viruses are found in 25% of patients, up to one-third of these have bacterial coinfection. Recent studies fail to identify a causative organism in more than 50% of cases, which remains the most important challenge to understanding lower respiratory infection. Our findings have important implications for antibiotic stewardship and should be considered as new policies for empiric pneumonia management are developed.

Citing Articles

Alterations in the prevalence and serotypes of Streptococcus pneumoniae in elderly patients with community-acquired pneumonia: a meta-analysis and systematic review.

Luo X, Yuan Q, Li J, Wu J, Zhu B, Lv M Pneumonia (Nathan). 2025; 17(1):5.

PMID: 39994753 PMC: 11852584. DOI: 10.1186/s41479-025-00156-0.


Description and characterization of pneumococcal community acquired pneumonia (CAP) among radiologically confirmed CAP in outpatients.

Le Bel J, Pinot J, Alfaiate T, Ecollan M, Cussac F, Pecqueur R NPJ Prim Care Respir Med. 2025; 35(1):1.

PMID: 39755706 PMC: 11700105. DOI: 10.1038/s41533-024-00405-7.


Pleural space infection microbiology as assessed using a clinical sequencing-based assay: group, and other oral normal microbiota are the most common bacteria identified in community-acquired pleural space infections.

Otero J, Mandrekar J, Wolf M, Starkey J, Carmona E, Dyrhovden R J Clin Microbiol. 2024; 62(12):e0069424.

PMID: 39584837 PMC: 11633145. DOI: 10.1128/jcm.00694-24.


Candent issues in pneumonia. Reflections from the Fifth Annual Meeting of Spanish Experts 2023.

Rodriguez-Leal C, Gonzalez-Corralejo C, Candel F, Salavert M Rev Esp Quimioter. 2024; 37(3):221-251.

PMID: 38436606 PMC: 11094633. DOI: 10.37201/req/018.2024.


Diabetes Status, c-Reactive Protein, and Insulin Resistance in Community-Acquired Pneumonia-A Prospective Cohort Study.

Matovu Dungu A, Ryrso C, Hegelund M, Jensen A, Kristensen P, Krogh-Madsen R J Clin Med. 2024; 13(1).

PMID: 38202252 PMC: 10780000. DOI: 10.3390/jcm13010245.


References
1.
Boerner D, Zwadyk P . The value of the sputum gram's stain in community-acquired pneumonia. JAMA. 1982; 247(5):642-5. View

2.
Sheppard C, Harrison T, Smith M, George R . Development of a sensitive, multiplexed immunoassay using xMAP beads for detection of serotype-specific streptococcus pneumoniae antigen in urine samples. J Med Microbiol. 2010; 60(Pt 1):49-55. DOI: 10.1099/jmm.0.023150-0. View

3.
Macfarlane J, Colville A, Guion A, Macfarlane R, Rose D . Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet. 1993; 341(8844):511-4. DOI: 10.1016/0140-6736(93)90275-l. View

4.
File Jr T, Low D, Eckburg P, Talbot G, Friedland H, Lee J . Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia. Clin Infect Dis. 2010; 51(12):1395-405. DOI: 10.1086/657313. View

5.
Moberley S, Holden J, Tatham D, Andrews R . Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev. 2013; (1):CD000422. PMC: 7045867. DOI: 10.1002/14651858.CD000422.pub3. View